The Fortune Business Insights adds Global "Iron Deficiency Anemia Therapy Market" 2023-2029 report that offers an total content of the assiduity with brief analysis, data maps, numbers, statistics that help take business opinions, company biographies and further.
The Complete report specifies the historical, present, and projected size of the market from the standpoint of both value and volume. SWOT and Value Chain Analysis are utilized to gauge the market. The market is very fragmented by type and application, with sales market share and rate of growth by type, application.
Also report compromises in-depth analysis covering key regional trends, market dynamics, and provides country-level market size of the worldwide Iron Deficiency Anemia Therapy Market.
Get a Free Sample Research PDF :
About Iron Deficiency Anemia Therapy Market Growth and Size
In January 2020, the U.S. FDA announced the approval of ferric derisomaltose injection of PHARMACOSMOS A/S for the treatment of iron deficiency anemia in adults who had an intolerance or unsatisfactory response to oral iron or who have nonhemodialysis-dependent chronic kidney disease.In December 2016, Nippon Shinyaku Enters into a License Agreement with PHARMACOSMOS A/S on an intravenous iron therapy, Monofer (Iron Isomaltoside 1000)
The global Iron Deficiency Anemia Therapy Market was valued at USD million in 2022 and is anticipated to reach USD million by 2029, witnessing a CAGR of during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American Iron Deficiency Anemia Therapy Market is estimated to increase from USD million in 2023 to reach USD million by 2029, at a CAGR of during the forecast period of 2023 through 2029.
Asia-Pacific Iron Deficiency Anemia Therapy Market is estimated to increase from USD million in 2023 to reach USD million by 2029, at a CAGR of during the forecast period of 2023 through 2029.
Iron Deficiency Anemia Therapy Market Research is spread across 100+ pages and provides exclusive data, information, vital statistics, trends and competitive landscape details in this niche sector.
Major Players in Iron Deficiency Anemia Therapy Market 2023 are:
Some of the major companies that are present in the iron deficiency anemia therapy market are Sanofi S.A., Allergan (AbbVie), PHARMACOSMOS A/S, Pieris, AMAG Pharmaceuticals, Bayer AG, Apotex Inc., Acceleron Pharma, Inc., and other prominent players.
For More Information :
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd
U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245